全球周边置入中央静脉导管市场

预计到 2030 年，全球周边置入中央静脉导管市场规模将达到 10 亿美元

全球周边置入中央静脉导管市场规模预计在2024年为8.683亿美元，预计到2030年将达到10亿美元，在2024-2030年的分析期内，复合年增长率为2.7%。传统PICC是本报告分析的细分市场之一，预计其复合年增长率为3.1%，到分析期结束时规模将达到6.389亿美元。动力注射PICC细分市场在分析期间的复合年增长率预计为2.2%。

美国市场规模估计为 2.366 亿美元，中国市场预计复合年增长率为 5.2%

美国周边置入中央静脉导管市场规模预计在2024年达到2.366亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到1.98亿美元，在2024-2030年的分析期内，复合年增长率为5.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.0%和2.1%。在欧洲，预计德国市场的复合年增长率为1.5%。

全球周边置入中央静脉导管市场－主要趋势与驱动因素摘要

为什么周边置入的中央静脉导管比传统的中心导管更受欢迎？

周边置入中央静脉导管(PICC) 因其微创特性和长期静脉治疗的多功能性，在临床上得到越来越广泛的应用。与需要插入锁骨下静脉或颈静脉的传统中央静脉导管不同，PICC 可插入週边静脉（通常是手臂）并推进至上腔静脉，从而为输液治疗提供更安全、更便捷的途径。这项优势对于接受化疗、肠外营养治疗或长期抗生剂治疗的患者尤其重要，因为这些患者需要长期血管路径。

PICC 的一大优点在于，它可由经过专门训练的护理人员在床边进行置管。此外，超音波和心电图导引留置技术显着提高了置管的准确性和安全性，最大限度地减少了气胸、动脉穿刺和导管误置等併发症。这些优势，加上置管成本的降低和患者舒适度的提升，使 PICC 成为住院和门诊病人首选的血管通路方法。

感染控制实务、抗菌技术和病患分层如何重新定义 PICC 的使用？

全球对临床照护感染预防的重视，尤其强调减少导管相关血流感染 (CABSI)。 PICC 製造商正积极研发具有抗菌涂层的先进导管材料，例如洛赫西定、银离子以及利福平和米诺四环素的组合。这些涂层不仅可以减少细菌定植，还能延长导管留置时间，使 PICC 在免疫力缺乏和重症患者中的长期使用更加可靠。

分层护理路径也影响PICC的使用模式。在肿瘤科，PICC可取代中心静脉导管，降低血栓症风险，并方便门诊化疗。在居家输液治疗中，患有慢性感染疾病和胃肠道疾病的患者现在可在流动医疗团队的支持下使用PICC进行治疗，从而提高治疗的连续性并降低再入院率。基于留置时间、输液类型和静脉状态的临床演算法正日益成为血管通路决策的指导原则，从而实现PICC的精准高效使用。

为什么技术进步和综合护理模式会提高市场采用率？

导管设计和置入方面的创新正在改善临床疗效和操作流程。能够承受高流速的强力注射式PICC导管在诊断影像和显影剂剂介入治疗中越来越受欢迎。此外，压力瓣膜、抗生物膜聚合物和固定装置的引入，最大限度地降低了导管脱位、堵塞和感染的风险，从而减少了併发症，改善了患者预后。

整合护理模式也在PICC市场扩张中发挥关键作用。医院正在组建专业的血管通路团队，以简化PICC置入、维护和移除通讯协定，规范最佳实践，并降低併发症发生率。在门诊和长期急性照护环境中，PICC正在被整合到慢性病管理框架中，并得到远端医疗监测和家庭照护的支持。

全球周边置入中央静脉导管市场的成长动力是什么？

周边置入中央静脉导管市场的成长受到多种因素的推动，例如长期静脉治疗需求的不断增长、医疗保健的日益分散以及感染控制技术的进步。主要成长要素是癌症患者、慢性感染疾病患者和老年患者群体的不断增长，他们需要安全且可重复的延长血管通路解决方案。

此外，全球范围内住院时间缩短以及向门诊和居家医疗转变的趋势，正在加速PICC在更广泛患者群体中的置入。注重成本控制、以病人为中心的照护和感染预防的医疗保健系统，正优先考虑PICC的临床和经济效益。随着可携式影像技术、即时置入指导和导管材料创新的融合，PICC市场必将不断扩张，成为已开发经济体和新兴经济体现代静脉通路策略的基石。

部分

产品类型（传统 PICC、动力注射 PICC、新生儿 PICC）、管腔类型（单腔、双腔、多腔）、应用（化疗、长期输液、肠外营养、输血、困难静脉通路、其他应用）、最终用途（医院、癌症研究机构、长期护理中心、独立输液中心、门诊手术中心、居家医疗机构、其他最终用途）

受访公司范例（总合42家公司）

• Access Vascular, Inc.
• AngioDynamics Inc.
• Argon Medical Devices, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Medical Inc.
• Health Line Medical Products
• ICU Medical, Inc.
• Kimal Plc
• Medical Components, Inc.
• Medtronic plc
• Merit Medical Systems, Inc.
• PFM Medical, Inc.
• Poly Medicure Ltd.
• Teleflex Incorporated
• Utah Medical Products, Inc.
• Vygon SA
• Zhejiang Haolang Technology Co., Ltd.

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Peripherally Inserted Central Catheters Market to Reach US$1.0 Billion by 2030

The global market for Peripherally Inserted Central Catheters estimated at US$868.3 Million in the year 2024, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 2.7% over the analysis period 2024-2030. Conventional PICC, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$638.9 Million by the end of the analysis period. Growth in the Power Injected PICC segment is estimated at 2.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$236.6 Million While China is Forecast to Grow at 5.2% CAGR

The Peripherally Inserted Central Catheters market in the U.S. is estimated at US$236.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$198.0 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Peripherally Inserted Central Catheters Market - Key Trends & Drivers Summarized

Why Are Peripherally Inserted Central Catheters Gaining Preference Over Conventional Central Lines?

Peripherally Inserted Central Catheters (PICCs) are witnessing increased clinical adoption due to their minimally invasive nature and versatility in delivering long-term intravenous therapies. Unlike traditional central venous catheters that require insertion in the subclavian or jugular vein, PICCs are inserted into peripheral veins (typically in the arm) and advanced to the superior vena cava, offering a safer and more accessible route for infusion therapy. This advantage is particularly crucial for patients undergoing chemotherapy, parenteral nutrition, or extended antibiotic regimens, where long-term vascular access is essential.

One of the key shifts favoring PICCs is their ability to be inserted at the bedside by specially trained nursing staff, eliminating the need for surgical suite occupancy and reducing procedural delays. Additionally, ultrasound and ECG-guided placement technologies have significantly enhanced insertion accuracy and safety, minimizing complications such as pneumothorax, arterial puncture, and catheter malposition. These benefits, combined with lower insertion costs and improved patient comfort, are propelling PICCs as the preferred vascular access method in both inpatient and outpatient care settings.

How Are Infection Control Standards, Antimicrobial Technologies, and Patient Stratification Redefining PICC Use?

The global focus on infection prevention in clinical care is placing significant emphasis on catheter-associated bloodstream infection (CABSI) reduction. PICC manufacturers are responding with advanced catheter materials embedded with antimicrobial coatings such as chlorhexidine, silver ions, or rifampin-minocycline combinations. These coatings not only reduce bacterial colonization but also extend dwell time, making PICCs more reliable for long-term use in immunocompromised and critically ill patients.

Stratified care pathways are also influencing PICC usage patterns. In oncology, PICCs offer a central line alternative that reduces the risk of thrombosis and facilitates outpatient chemotherapy regimens. In home infusion therapy, patients with chronic infections or gastrointestinal disorders are now managed via PICCs supported by mobile care teams, improving continuity and reducing hospital readmission rates. Clinical algorithms based on dwell time, infusion type, and venous condition are increasingly guiding vascular access decisions, leading to more targeted and efficient use of PICCs.

Why Are Technological Advancements and Integrated Care Models Expanding Market Adoption?

Innovations in catheter design and placement are enhancing clinical outcomes and procedural workflow. Power-injectable PICCs capable of withstanding high flow rates are gaining popularity in diagnostic imaging and contrast-based interventions. Additionally, the introduction of pressure-sensitive valves, biofilm-resistant polymers, and securement devices is minimizing the risk of catheter dislodgment, occlusion, and infection-leading to fewer complications and improved patient outcomes.

Integrated care models are also playing a key role in expanding the PICC market. Hospitals are establishing dedicated vascular access teams that streamline PICC placement, maintenance, and removal protocols, thus standardizing best practices and reducing complication rates. In ambulatory care and long-term acute care settings, PICCs are being embedded into chronic disease management frameworks, supported by telehealth monitoring and home care nursing-extending the reach of central venous access beyond the hospital walls.

What’s Driving the Growth of the Peripherally Inserted Central Catheters Market Worldwide?

The growth in the peripherally inserted central catheters market is driven by several factors including the increasing need for long-term intravenous therapy, rising healthcare decentralization, and advancements in infection control technologies. A primary growth driver is the growing population of cancer patients, individuals with chronic infections, and elderly patients who require safe, repeatable, and extended vascular access solutions.

Additionally, the global trend toward reducing hospital stays and shifting care to outpatient or home-based models is accelerating PICC placement across a broader patient base. Health systems focused on cost containment, patient-centered care, and infection prevention are prioritizing PICCs for their clinical and economic advantages. With the convergence of portable imaging, real-time placement guidance, and catheter material innovation, the PICC market is set to expand as a cornerstone of modern intravenous access strategies in both developed and emerging economies.

SCOPE OF STUDY:

The report analyzes the Peripherally Inserted Central Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Conventional PICC, Power Injected PICC, Neonatal PICC); Lumen Type (Single Lumen, Double Lumen, Multiple Lumen); Application (Chemotherapy, Long-Term Iv Infusion, Parenteral Nutrition, Blood Transfusion, Difficult Intravenous Access, Other Applications); End-Use (Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Access Vascular, Inc.
• AngioDynamics Inc.
• Argon Medical Devices, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Medical Inc.
• Health Line Medical Products
• ICU Medical, Inc.
• Kimal Plc
• Medical Components, Inc.
• Medtronic plc
• Merit Medical Systems, Inc.
• PFM Medical, Inc.
• Poly Medicure Ltd.
• Teleflex Incorporated
• Utah Medical Products, Inc.
• Vygon SA
• Zhejiang Haolang Technology Co., Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Peripherally Inserted Central Catheters - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Chronic Illness and Long-Term IV Therapy Requirements Spurs Demand for PICCs
  • Expansion of Home Infusion Therapy and Outpatient Oncology Throws the Spotlight on PICC Line Convenience
  • OEM Innovation in Antimicrobial and Antithrombogenic Coatings Enhances Infection Control in PICC Devices
  • Growth in Central Venous Access Procedures Supports Adoption of Ultrasound-Guided PICC Insertions
  • OEM Development of Power-Injectable and MRI-Compatible PICCs Expands Diagnostic and Therapeutic Flexibility
  • Surging Demand for Vascular Access Devices in Pediatric and Geriatric Populations Drives Segment Differentiation
  • OEM Focus on Easy Insertion Techniques and Port Design Enhances Safety and Physician Preference
  • Increase in ICU and Post-Surgical Care Volumes Propels Use of Central Line Alternatives
  • OEM Collaboration With Home Health Agencies and Nursing Services Supports Training and Education Initiatives
  • Rising Emphasis on Central Line-Associated Bloodstream Infection (CLABSI) Prevention Boosts Market for PICCs
  • OEM Advances in Single-Lumen and Multi-Lumen Designs Supports Tailored Therapy Administration
  • Expansion of Midline and Hybrid Catheter Markets Spurs PICC Innovations in Length, Gauge, and Flexibility
  • OEM Integration of Electronic Documentation and Barcode Scanning Enhances Traceability and Compliance
  • Growth in Personalized IV Drug Delivery and Parenteral Nutrition Supports Sustained PICC Use
  • OEM Emphasis on Biocompatible Materials and Long-Term Dwell Time Enhances Patient Satisfaction
  • Regulatory Focus on Insertion Site Sterility and Maintenance Protocols Drives Adoption of Best-In-Class PICC Systems
  • OEM Investment in Catheter Securement and Dressing Accessories Strengthens Ancillary Product Sales
  • Surge in Procedural Reimbursement and Favorable Cost-Benefit Ratios Supports PICC Selection Over Ports and TIVADs
  • OEM Differentiation Through Patient Comfort and Soft-Tip Technology Improves Clinical Outcomes
  • Global Standardization of Vascular Access Training Enhances Skilled PICC Placement Capacity Across Regions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Peripherally Inserted Central Catheters Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Peripherally Inserted Central Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Peripherally Inserted Central Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Conventional PICC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Conventional PICC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Conventional PICC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Power Injected PICC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Power Injected PICC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Power Injected PICC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Neonatal PICC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Neonatal PICC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Neonatal PICC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Blood Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Blood Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Blood Transfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Difficult Intravenous Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Difficult Intravenous Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Difficult Intravenous Access by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Long-Term Iv Infusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Long-Term Iv Infusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Long-Term Iv Infusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Cancer Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Cancer Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Cancer Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Long Term Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Long Term Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Long Term Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Independent Infusion Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Independent Infusion Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Independent Infusion Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Ambulatory Surgical Center by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Ambulatory Surgical Center by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Ambulatory Surgical Center by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Single Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Single Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Single Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Double Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Double Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Double Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Multiple Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Multiple Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for Multiple Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 62: USA Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: USA 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Canada 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• JAPAN
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Japan 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Japan 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Japan 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Japan 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• CHINA
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 98: China Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: China 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 101: China Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: China 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 104: China Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: China 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: China 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• EUROPE
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Peripherally Inserted Central Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Europe 15-Year Perspective for Peripherally Inserted Central Catheters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Europe 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Europe 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Europe 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Europe 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• FRANCE
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 125: France Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: France 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 128: France Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: France 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 131: France Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: France Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: France 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 134: France Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: France Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: France 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• GERMANY
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Germany 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Germany 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 143: Germany Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Germany Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Germany 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Germany Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Germany 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Italy Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Italy 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Italy 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 155: Italy Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Italy Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Italy 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 158: Italy Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Italy Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Italy 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 161: UK Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: UK Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: UK 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 164: UK Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: UK 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 167: UK Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: UK Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: UK 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 170: UK Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: UK Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: UK 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Spain Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Spain 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Spain 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 179: Spain Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Spain Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Spain 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 182: Spain Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Spain Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Spain 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Russia Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Russia 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Russia 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 191: Russia Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Russia Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Russia 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 194: Russia Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Russia Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Russia 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Europe 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Europe Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Europe 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Europe Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Europe 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Peripherally Inserted Central Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 15-Year Perspective for Peripherally Inserted Central Catheters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Asia-Pacific Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Asia-Pacific 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Asia-Pacific Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Asia-Pacific 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Australia Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Australia 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Australia 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 230: Australia Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Australia Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Australia 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 233: Australia Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Australia Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Australia 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• INDIA
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 236: India Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: India Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: India 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 239: India Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: India 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 242: India Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: India Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: India 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 245: India Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: India Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: India 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: South Korea Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: South Korea 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: South Korea 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 254: South Korea Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: South Korea Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: South Korea 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 257: South Korea Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: South Korea Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: South Korea 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Rest of Asia-Pacific Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Rest of Asia-Pacific 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Rest of Asia-Pacific Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Rest of Asia-Pacific 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Peripherally Inserted Central Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Latin America 15-Year Perspective for Peripherally Inserted Central Catheters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Latin America 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Latin America 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 281: Latin America Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Latin America Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Latin America 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 284: Latin America Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Latin America Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Latin America 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Argentina Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Argentina 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Argentina 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 293: Argentina Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Argentina Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Argentina 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 296: Argentina Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Argentina Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Argentina 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Brazil Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Brazil 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Brazil 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 305: Brazil Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Brazil Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Brazil 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 308: Brazil Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Brazil Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Brazil 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Mexico Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Mexico 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Mexico 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 317: Mexico Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Mexico Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Mexico 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 320: Mexico Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Mexico Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Mexico 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Rest of Latin America 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Latin America Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Rest of Latin America 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Rest of Latin America Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Rest of Latin America 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Peripherally Inserted Central Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Middle East 15-Year Perspective for Peripherally Inserted Central Catheters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Middle East 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Middle East 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 344: Middle East Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Middle East Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Middle East 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 347: Middle East Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Middle East Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Middle East 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Iran Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Iran 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Iran 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 356: Iran Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Iran Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Iran 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 359: Iran Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Iran Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Iran 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Israel Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: Israel 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: Israel 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 368: Israel Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Israel Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: Israel 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 371: Israel Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Israel Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: Israel 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: Saudi Arabia 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Saudi Arabia Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Saudi Arabia 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Saudi Arabia Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Saudi Arabia 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: UAE Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: UAE 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: UAE 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 392: UAE Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: UAE Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: UAE 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 395: UAE Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: UAE Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: UAE 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 400: Rest of Middle East 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Middle East Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 406: Rest of Middle East 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Middle East Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 409: Rest of Middle East 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030
• AFRICA
  • Peripherally Inserted Central Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Africa Historic Review for Peripherally Inserted Central Catheters by Product Type - Conventional PICC, Power Injected PICC and Neonatal PICC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 412: Africa 15-Year Perspective for Peripherally Inserted Central Catheters by Product Type - Percentage Breakdown of Value Sales for Conventional PICC, Power Injected PICC and Neonatal PICC for the Years 2015, 2025 & 2030
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Peripherally Inserted Central Catheters by Application - Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 415: Africa 15-Year Perspective for Peripherally Inserted Central Catheters by Application - Percentage Breakdown of Value Sales for Blood Transfusion, Difficult Intravenous Access, Other Applications, Chemotherapy, Long-Term Iv Infusion and Parenteral Nutrition for the Years 2015, 2025 & 2030
  • TABLE 416: Africa Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Africa Historic Review for Peripherally Inserted Central Catheters by End-Use - Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 418: Africa 15-Year Perspective for Peripherally Inserted Central Catheters by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cancer Research Institutes, Long Term Care Centers, Independent Infusion Centers, Ambulatory Surgical Center, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 419: Africa Recent Past, Current & Future Analysis for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Africa Historic Review for Peripherally Inserted Central Catheters by Lumen Type - Single Lumen, Double Lumen and Multiple Lumen Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 421: Africa 15-Year Perspective for Peripherally Inserted Central Catheters by Lumen Type - Percentage Breakdown of Value Sales for Single Lumen, Double Lumen and Multiple Lumen for the Years 2015, 2025 & 2030

IV. COMPETITION